Conservative Fluid Resuscitation Protocol Does Not Reduce the Incidence of Reoperation for Bleeding during the First 48 Hours after Emergency CABG

Author:

Bruno Jowita1,Varayath Mascha1,Gahl Brigitta1,Miazza Jules1,Gebhard Caroline E.1,Reuthebuch Oliver T.1,Eckstein Friedrich S.1,Siegemund Martin1,Hollinger Alexa1,Santer David1

Affiliation:

1. University Hospital Basel

Abstract

Abstract BACKGROUND Reoperation for bleeding (ROB) after emergency coronary artery bypass grafting (CABG) has been identified as an independent risk factor for mortality with the incidence of in-hospital death ranging from 9–22%. A potential cause might be coagulopathy induced by dilution due to liberal fluid management. The aim of this study was to evaluate the effects of two volume resuscitation protocols on ROB after CABG.METHODS In this retrospective single-center study, all patients who underwent emergency CABG (n = 265) at our institution between 2011 and 2020 were included. From 2018, postoperative hemodynamic management was performed with lower volume administration and higher vasoactive support. The primary outcome measure was the incidence of ROB within 48 hours after intensive care unit admission according to altered fluid resuscitation strategy. Consecutively, the influence of fluid intake, fluid output, fluid balance, blood loss, and inotropic demand on ROB were analyzed.RESULTS The incidence of ROB was independent from the volume resuscitation protocol (P = .3). The ROB group had a higher perioperative risk, which was observed in EuroSCORE II and laboratory values. Fluid intake (P = .021), fluid balance (P = .001), and norepinephrine administration (P = .004) were associated with ROB. Fluid output and blood loss were not associated with ROB (P = .22). Post-test probability was low among all variables.CONCLUSIONS Although fluid management might have an impact on specific postoperative complications, different fluid resuscitation protocols did not alter the incidence of ROB after emergency CABG.Ethics approval and consent to participate: This study has been approved by the Ethics Committee of Northwestern and Central Switzerland. (Project-ID: 2020 − 01833)Trial registration: www.clinicaltrials.gov registration number NCT04533698; date of registration: August 31, 2020 (retrospectively registered due to nature of the study)

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3